Klaus Strein is a German businessperson who founded EngMab SARL and who has been at the helm of 5 different companies. Presently, he occupies the position of Chairman for Lamkap Bio AG, Chairman-Supervisory Board for Lamkap Bio Alpha AG, Chairman-Supervisory Board of Lamkap Bio Beta AG, Chairman-Supervisory Board at Lamkap Bio Gamma AG and Chairman at EngMab SARL.
He is also on the board of BB Biotech AG, Novimmune SA and Light Chain Biosciences AG.
Klaus Strein previously occupied the position of Head-Small Molecules Research at Roche Holding AG.
Dr. Strein received a doctorate from Ruprecht-Karls-Universität Heidelberg.